Kevzara® (sarilumab) Data at the 2018 ACR/ARHP Annual Meeting Provide Additional Insight on Safety and Efficacy in Rheumatoid Arthritis

Regeneron Contacts:

Sanofi Contacts:

Media Relations

Media Relations

Sarah Cornhill

Ashleigh Koss

Tel: +1 (914) 847-5018

Tel: +1 (908) 981-8745

[email protected]

[email protected]

Investor Relations

Investor Relations

Manisha Narasimhan, Ph.D.

George Grofik

Tel: +1 (914) 847-5126

Tel: +33 (0)1 53 77 45 45

[email protected]

[email protected]